Boots introduces new at-home health checks
The tests include vitamin D, cholesterol, diabetes, and iron deficiency among others.
Read More
Tag: Iron Deficiency
Norgine launches Shield’s Feraccru in the UK
Norgine has launched Feraccru across the UK to treat patients with iron deficiency anaemia, having picked up rights to sell the drug from Shield Therapeutics earlier this year.
Read More
Shield’s Feraccru accepted for review in the US
Shield Therapeutics’ iron deficiency drug Feraccru has been accepted for review by the US Food and Drug Administration (FDA).
Read More
Shield files Feraccru with the FDA
The UK’s Shield Therapeutics has successfully submitted an application to market iron deficiency therapy Feraccru in the US.
Read More
Norgine buys rights to sell Shield’s iron deficiency therapy
Norgine has signed a deal with Shield Therapeutics allowing it to commercialise iron deficiency therapy Feraccru in Europe, Australia and New Zealand.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
